Phone : +33 9 61 62 65 17 • Email : contact@metafora-biosystems.com
Site logo
Sticky header logo
Mobile logo
  • HOME
  • WHAT WE DO
  • ABOUT US
    • LEARN +
  • METAGLUT1
  • PARTNERSHIP
  • NEWS
  • CONTACT
HomeArchive by Category "Our Tests"

Our Tests

Our Tests First patient inclusion of the METAglut1 study
septembre 24, 2018

First patient inclusion of the METAglut1 study

Our Tests METAglut1 gets CE marked
février 15, 2017

METAglut1 gets CE marked

Our Tests Our innovative technology becomes available for patients
février 7, 2017

Our innovative technology becomes available for patients

> SEE ALL NEWS…

RECENT NEWS

  • METAFORA prizewinner of the « Concours d’Innovation » / Bpifrance février 20, 2019
  • First patient inclusion of the METAglut1 study septembre 24, 2018
  • 2nd European Conference on Glut1 Deficiency- Matthews Friends, 22nd-23rd June 2018, Grinstead, UK juillet 13, 2018
  • SNEP 2018, 27-28 April, Barcelone juin 23, 2018
  • METAFORA receives €3.2 M from H2020 SME Instrument program juin 11, 2018

CATEGORIES

  • Award (3)
  • Company (8)
  • Events (4)
  • Our Tests (3)
  • Publications (5)
Image module

We target cell metabolism

METAFORA biosystems

Pépinière Paris Biotech Santé
29 rue du Faubourg Saint Jacques,
75014 Paris, France

Phone: +33 9 61 62 65 17

contact@metafora-biosystems.com

RECENT NEWS

Award METAFORA prizewinner of the « Concours d’Innovation » / Bpifrance

METAFORA prizewinner of the « Concours d’Innovation » / Bpifrance

février 20, 2019
Our Tests First patient inclusion of the METAglut1 study

First patient inclusion of the METAglut1 study

septembre 24, 2018

FOLLOW US

  • Linkedin
  • Twitter
  • YouTube

Legal mentions   |   Privacy policy

2018 © METAFORA biosystems
div#stuning-header .dfd-stuning-header-bg-container {background-size: initial;background-position: top center;background-attachment: initial;background-repeat: initial;}#stuning-header div.page-title-inner {min-height: 100px;}#main-content .dfd-content-wrap {margin: -10px;} #main-content .dfd-content-wrap > article {padding: 10px;}@media only screen and (min-width: 1101px) {#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars {padding: 0 20px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars > #main-content > .dfd-content-wrap:first-child {border-top: 20px solid transparent; border-bottom: 10px solid transparent;}#layout.dfd-portfolio-loop > .row.full-width #right-sidebar,#layout.dfd-gallery-loop > .row.full-width #right-sidebar {padding-top: 10px;padding-bottom: 10px;}#layout.dfd-portfolio-loop > .row.full-width > .blog-section.no-sidebars .sort-panel,#layout.dfd-gallery-loop > .row.full-width > .blog-section.no-sidebars .sort-panel {margin-left: -20px;margin-right: -20px;}}#layout .dfd-content-wrap.layout-side-image,#layout > .row.full-width .dfd-content-wrap.layout-side-image {margin-left: 0;margin-right: 0;}
We use cookies to guarantee you the best experience on our website. If you continue to use this site, we will assume that you are satisfied with it.OK